Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond

SIMPLE SUMMARY: Biomarker research for immunotherapy in gastroesophageal cancer has been rapidly developing in parallel with the growing use of immune checkpoint inhibitors. Although several biomarkers have been approved for use in the clinical setting they are imperfect in predicting responses. Sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Robin, Da Silva, Laercio Lopes, Saeed, Anwaar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038572/
https://www.ncbi.nlm.nih.gov/pubmed/33916348
http://dx.doi.org/10.3390/cancers13071715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038572/
https://www.ncbi.nlm.nih.gov/pubmed/33916348
http://dx.doi.org/10.3390/cancers13071715

Ejemplares similares